Search for: "Price v. HHS" Results 61 - 80 of 122
Sort by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
18 Oct 2018, 9:30 pm by Bobby Chen
After Parker v. [read post]
7 Sep 2018, 10:44 am by luiza
Although Silver’s complaint included publicly available information, his personal knowledge of non-public information about defendant PharMerica’s pricing was critical to his allegations of fraudulent conduct. [read post]
1 Oct 2017, 4:08 pm by INFORRM
Price, University of California Hastings College of the Law. [read post]
12 Jul 2017, 3:50 am by Kevin LaCroix
John Stark Reed Readers undoubtedly are aware of the recent outbreak of ransomware incidents and the problems they present. [read post]
27 Apr 2017, 1:30 am by Thaddeus Mason Pope, JD, PhD
Wei Li, Montefiore East Tremont Practice, Off¬Label Medical Device use by Surgeons Public Health Law Session 1E – Room 242Overarching Themes in Public Health LawModerator: Jonathan Todres, Georgia State University College of LawLance Gable, Wayne State University Law School, Public and Private Models of Public Health Governance in Trump’s AmericaLewis Grossman, American University Washington College of Law, The Taming of Progressive ‘State Medicine’James Hodge, Arizona… [read post]
14 Apr 2017, 4:17 pm by INFORRM
The rising importance of of data protection law has been illustrated by a number of cases, notably HH Prince Hicham Ben Abullah Al Alaoui v Elaph Publishing [2017] EWCA Civ 29)(on the overlap between libel and data protection) and Stunt v Associated Newspapers [2017] EWHC 695 (QB). [read post]
“Specialty drugs” are a fast growing sector of the pharmaceutical industry and are predicated to represent 50 percent of drug expenditures in the United States by 2020.[1] Specialty drugs are typically dispensed by specialty pharmacies. [read post]
19 Jan 2017, 9:30 pm by Justin Daniel
Department of Health and Human Services (HHS), U.S. [read post]